2019
type: Class

Research Organization
type: Class

Anualidad
type: Class

Research Activity Report
type: Class

RDF description of Moléculas bioactivas 2019 - http://research.umh.es/vivo/pub/memoria/2019/gi_1079
type: Document
rights: termsOfUse
date: 2026-08-13T23:21:09
publisher: Moléculas bioactivas 2019

Moléculas bioactivas 2019
type: 2019
includes: Fluorescence-Based Functional Assays for Ca2+-Permeable ThermoTRP Channels
includes: A positive allosteric modulator of alpha7 nicotinic receptors with analgesic and neuroprotective activity.
includes: 7TH SPANISH-ITALIAN-PORTUGUESE-FRENCH (SIPF) INTERNATIONAL WORKSHOP ON STRUCTURE AND FUNCTION OF ION CHANNELS AND TRANSPORTERS (Congress Organization)
includes: Transdifferentiation and microfluidic chambers as tools to approach thein-vivosketch of human nociceptors.
most specific type: 2019
includes: XI JORNADA DE SAN ALBERTO MAGNO (Congress Organization)
includes: A capsaicin-based TRPV1 soft antagonist as an anti-pruritic drug candidate
includes: In vitro characterization of a TRPV1 soft antagonist.
includes: INNTAL11/19/011
includes: A capsaicin-based TRPV1 soft antagonist as an anti-pruritic drug candidate.
includes: ANTALGENICS4.18LP
includes: DQ0094VF
includes: A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.
includes: VII REUNIÓN DE LA RED ESPAÑOLA DE CANALES IÓNICOS / RECI VII (Congress Organization)
includes: Development of a New Delivery System Based on Drug-Loadable Electrospun Nanofibers for Psoriasis Treatment
includes: 1¿(2¿,5¿-Dihydroxyphenyl)-3-(2-fluoro-4-hydroxyphenyl)-1- propanone (RGM079): A Positive Allosteric Modulator of ¿7 Nicotinic Receptors with Analgesic and Neuroprotective Activity
includes: Modulation of TRPV1 channels: from bench to bedside.
includes: In vivo role of TRP channels in an experimental model of chronic migraine.
includes: http://research.umh.es/vivo/pub/articulo/199350
includes: FERNÁNDEZ BALLESTER, GREGORIO JOAQUIN
includes: SAF2015-66275-C2-1-R
includes: LIPOTEC2.16R
includes: ALODIA1.17LP
includes: RTC-2017-6507-1
included: Moléculas bioactivas
type: Thing
most specific type: Research Organization
includes: IDIFEDER/2018/020
includes: In Silico Approaches for TRP Channel Modulation
includes: Overexpression of P2X3 and P2X7 Receptors and TRPV1 Channels in Adrenomedullary Chromaffin Cells in a Rat Model of Neuropathic Pain.
includes: ANTALGENICS2.18SC
relates: Moléculas bioactivas
includes: 12TH EBSA 10TH ICBP-IUPAP CONGRESS (Congress Organization)
includes: A new family of chiral heterocyclic compounds that blocks the TRPM8 activation.
includes: FASTBASE1.16ET
includes: Study Chronic Effect of 17- ß -Estradiol Over Trp Channels In Nociceptor Terminals In Microfluidic Chambers.
includes: FERNÁNDEZ CARVAJAL, ASIA
includes: Mechanisms of blockade of the muscle-type nicotinic receptor by benzocaine, a permanently uncharged local anesthetic
includes: FERRER MONTIEL, ANTONIO VICENTE
includes: The calmodulin-binding tetraleucine motif of KCNE4 is responsible for association with Kv1.3
includes: Development of an in vitro pre-clinical nociceptor model for studying paclitaxel-induced neuropathic pain"
includes: Transdifferentiation and microfluidic chambers as tools to approach the in-vivo sketch of human nociceptors
includes: Identificación y caracterización de nuevos moduladores de TRPM8
includes: RTI2018-097189-B-C21
includes: GRISOLIA
includes: PROSPERABIOTECH1.16ET
includes: Development of an in vitro pre-clinical nociceptor model for studying paclitaxel-induced neuropathic pain
includes: Contribution of hyperpolarizing ion channels to acute cold hypersensitivity induced by oxaliplatin administration.
type: Research Activity Report
type: Anualidad
includes: AVIZOREX1.16LP
includes: LIPOTEC1.99R
includes: ANTALGENICS1.15ET
includes: Improving a Natural Compound: Design of innovative neurocosmeceuticals for sensitive skin
includes: LIPOTEC1.14D
includes: ß -Lactam TRPM8 Antagonists Prevent Chemotherapy-Induced Cold Allodynia.
type: Research Organization

Fluorescence-Based Functional Assays for Ca2+-Permeable ThermoTRP Channels
type: 2019
type: Chapter
type: BFO_0000002
included: Moléculas bioactivas 2019
type: Document
type: BFO_0000001
type: Anualidad
type: BookSection
type: BFO_0000031
type: DocumentPart
type: Thing
type: IAO_0000030

A positive allosteric modulator of alpha7 nicotinic receptors with analgesic and neuroprotective activity.
type: BFO_0000001
included: Moléculas bioactivas 2019
type: Article
type: IAO_0000030
type: 2019
type: AcademicArticle
type: BFO_0000031
type: Document
type: Anualidad
type: Thing
type: BFO_0000002

7TH SPANISH-ITALIAN-PORTUGUESE-FRENCH (SIPF) INTERNATIONAL WORKSHOP ON STRUCTURE AND FUNCTION OF ION CHANNELS AND TRANSPORTERS (Congress Organization)
type: Anualidad
type: ConferenceOrganization
type: Event
included: Moléculas bioactivas 2019
type: 2019
type: Thing
type: BFO_0000001
type: BFO_0000003
type: BFO_0000015

Transdifferentiation and microfluidic chambers as tools to approach thein-vivosketch of human nociceptors.
type: Document
type: BFO_0000031
type: 2019
type: Thing
type: Anualidad
type: Conference
type: ConferencePoster
type: BFO_0000001
included: Moléculas bioactivas 2019
type: IAO_0000030
type: BFO_0000002

XI JORNADA DE SAN ALBERTO MAGNO (Congress Organization)
type: BFO_0000003
type: BFO_0000015
type: Thing
type: 2019
type: ConferenceOrganization
type: Anualidad
type: BFO_0000001
included: Moléculas bioactivas 2019
type: Event

A capsaicin-based TRPV1 soft antagonist as an anti-pruritic drug candidate
type: Document
included: Moléculas bioactivas 2019
type: BFO_0000002
type: 2019
type: IAO_0000030
type: Thing
type: Conference
type: BFO_0000001
type: BFO_0000031
type: Anualidad
type: ConferencePoster

In vitro characterization of a TRPV1 soft antagonist.
type: BFO_0000001
included: Moléculas bioactivas 2019
type: BFO_0000002
type: Document
type: 2019
type: Article
type: IAO_0000030
type: Thing
type: BFO_0000031
type: ConferencePaper
type: Anualidad
type: Conference

INNTAL11/19/011
type: BFO_0000015
type: Grant
type: BFO_0000020
type: ProyectoInvestigacion
type: BFO_0000002
type: BFO_0000001
type: Anualidad
type: 2019
type: Year2020
type: Project
type: Proyecto
type: Thing
type: Relationship
type: BFO_0000003
included: Moléculas bioactivas 2019
type: OBI_0000011
type: ERO_0000014

A capsaicin-based TRPV1 soft antagonist as an anti-pruritic drug candidate.
type: IAO_0000030
type: Document
type: 2019
type: BFO_0000031
type: Conference
type: BFO_0000001
type: ConferencePoster
type: Thing
included: Moléculas bioactivas 2019
type: Anualidad
type: BFO_0000002

ANTALGENICS4.18LP
type: Project
type: BFO_0000015
type: ExplotacionLicencia
type: Proyecto
type: BFO_0000020
type: Relationship
included: Moléculas bioactivas 2019
type: BFO_0000003
type: Year2021
type: 2019
type: Thing
type: BFO_0000002
type: Year2018
type: Anualidad
type: Grant
type: TransferenciaTecnologica
type: Year2020
type: BFO_0000001

DQ0094VF
type: Proyecto
type: OBI_0000011
type: BFO_0000015
type: Project
included: Moléculas bioactivas 2019
type: BFO_0000003
type: BFO_0000020
type: ProyectoInvestigacion
type: Anualidad
type: Grant
type: ERO_0000014
type: Thing
type: BFO_0000001
type: 2019
type: BFO_0000002
type: Relationship

A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.
type: Thing
type: 2019
type: Anualidad
type: Article
type: BFO_0000002
type: BFO_0000001
type: BFO_0000031
type: IAO_0000030
included: Moléculas bioactivas 2019
type: Document
type: AcademicArticle

VII REUNIÓN DE LA RED ESPAÑOLA DE CANALES IÓNICOS / RECI VII (Congress Organization)
type: BFO_0000003
type: Anualidad
type: Thing
type: BFO_0000015
included: Moléculas bioactivas 2019
type: BFO_0000001
type: 2019
type: Event
type: ConferenceOrganization

Development of a New Delivery System Based on Drug-Loadable Electrospun Nanofibers for Psoriasis Treatment
type: Document
type: BFO_0000001
type: BFO_0000031
included: Moléculas bioactivas 2019
type: IAO_0000030
type: 2019
type: AcademicArticle
type: Anualidad
type: Thing
type: BFO_0000002
type: Article

1¿(2¿,5¿-Dihydroxyphenyl)-3-(2-fluoro-4-hydroxyphenyl)-1- propanone (RGM079): A Positive Allosteric Modulator of ¿7 Nicotinic Receptors with Analgesic and Neuroprotective Activity
type: Anualidad
type: AcademicArticle
included: Moléculas bioactivas 2019
type: 2019
type: Thing
type: BFO_0000002
type: Document
type: Article
type: IAO_0000030
type: BFO_0000001
type: BFO_0000031

Modulation of TRPV1 channels: from bench to bedside.
type: IAO_0000030
type: Article
type: BFO_0000001
type: Thing
type: Anualidad
type: Conference
included: Moléculas bioactivas 2019
type: BFO_0000002
type: BFO_0000031
type: ConferencePaper
type: Document
type: 2019

In vivo role of TRP channels in an experimental model of chronic migraine.
type: Conference
type: Document
type: ConferencePoster
type: BFO_0000031
included: Moléculas bioactivas 2019
type: Anualidad
type: BFO_0000002
type: IAO_0000030
type: 2019
type: Thing
type: BFO_0000001

http://research.umh.es/vivo/pub/articulo/199350
type: BFO_0000001
included: Moléculas bioactivas 2019
type: Document
type: IAO_0000030
type: 2019
type: BFO_0000002
type: Thing
type: Article
type: AcademicArticle
type: Anualidad
label: Structure-based design of novel biphenyl amide antagonists of human Transient Receptor Potential Cation Channel Subfamily M Member 8 channels (TRPM8) with potential implications in the treatment of sensory neuropathies.
type: BFO_0000031

FERNÁNDEZ BALLESTER, GREGORIO JOAQUIN
type: PersonActive
type: Agent
type: BFO_0000001
type: Person
type: Thing
type: BFO_0000004
type: BFO_0000002
included: Moléculas bioactivas 2019

SAF2015-66275-C2-1-R
type: BFO_0000003
type: Grant
type: ERO_0000014
type: Thing
type: OBI_0000011
included: Moléculas bioactivas 2019
type: Proyecto
type: BFO_0000020
type: ProyectoInvestigacion
type: Relationship
type: Year2018
type: Anualidad
type: BFO_0000015
type: 2019
type: Project
type: Year2017
type: BFO_0000001
type: BFO_0000002

LIPOTEC2.16R
type: Year2017
type: TransferenciaTecnologica
type: BFO_0000015
type: BFO_0000002
type: BFO_0000020
type: Year2020
type: BFO_0000001
type: 2019
type: Grant
type: BFO_0000003
type: Thing
type: Anualidad
type: Project
included: Moléculas bioactivas 2019
type: ExplotacionLicencia
type: Relationship
type: Year2018
type: Proyecto

ALODIA1.17LP
type: 2019
type: Year2020
type: Grant
type: Year2021
type: Project
type: BFO_0000002
type: Anualidad
type: ExplotacionLicencia
type: Proyecto
type: Year2017
type: Year2018
included: Moléculas bioactivas 2019
type: Relationship
type: Thing
type: BFO_0000001
type: BFO_0000015
type: TransferenciaTecnologica
type: BFO_0000003
type: BFO_0000020

RTC-2017-6507-1
type: Proyecto
included: Moléculas bioactivas 2019
type: ProyectoInvestigacion
type: Year2020
type: Thing
type: ERO_0000014
type: Year2018
type: BFO_0000001
type: Grant
type: Year2021
type: BFO_0000003
type: OBI_0000011
type: Project
type: Relationship
type: 2019
type: BFO_0000002
type: Anualidad
type: BFO_0000015
type: BFO_0000020

In vitro characterization of a TRPV1 soft antagonist.
type: 2019
included: Moléculas bioactivas 2019
type: BFO_0000031
type: BFO_0000002
type: BFO_0000001
type: ConferencePoster
type: Thing
type: Anualidad
type: Conference
type: Document
type: IAO_0000030

Moléculas bioactivas
type: BFO_0000004
type: ResearchOrganization
type: BFO_0000001
type: ResearchOrganizationActive
includes: Moléculas bioactivas 2019
type: Organization
type: Agent
type: BFO_0000002
related by: Moléculas bioactivas 2019
type: Thing

IDIFEDER/2018/020
type: BFO_0000015
type: BFO_0000020
type: BFO_0000001
type: 2019
type: BFO_0000003
type: Anualidad
type: OBI_0000011
type: ProyectoInvestigacion
type: BFO_0000002
type: Relationship
type: ERO_0000014
type: Year2020
type: Grant
included: Moléculas bioactivas 2019
type: Thing
type: Proyecto
type: Project
type: Year2018

In Silico Approaches for TRP Channel Modulation
type: Document
type: BFO_0000001
type: IAO_0000030
type: Anualidad
type: Chapter
included: Moléculas bioactivas 2019
type: BFO_0000002
type: DocumentPart
type: BFO_0000031
type: 2019
type: BookSection
type: Thing

Overexpression of P2X3 and P2X7 Receptors and TRPV1 Channels in Adrenomedullary Chromaffin Cells in a Rat Model of Neuropathic Pain.
type: BFO_0000002
type: Article
type: Anualidad
type: IAO_0000030
type: BFO_0000001
included: Moléculas bioactivas 2019
type: Document
type: BFO_0000031
type: AcademicArticle
type: Thing
type: 2019

ANTALGENICS2.18SC
type: ProyectoInvestigacion
included: Moléculas bioactivas 2019
type: OBI_0000011
type: ProyectoTerceros
type: BFO_0000015
type: 2019
type: Thing
type: BFO_0000001
type: BFO_0000020
type: Proyecto
type: Grant
type: BFO_0000002
type: BFO_0000003
type: Anualidad
type: ERO_0000014
type: Year2020
type: Year2018
type: Relationship
type: Project

12TH EBSA 10TH ICBP-IUPAP CONGRESS (Congress Organization)
type: ConferenceOrganization
type: BFO_0000015
included: Moléculas bioactivas 2019
type: BFO_0000001
type: Anualidad
type: 2019
type: Thing
type: Event
type: BFO_0000003

In vitro characterization of a TRPV1 soft antagonist.
type: Document
type: 2019
type: BFO_0000001
type: BFO_0000031
type: Anualidad
type: Conference
type: IAO_0000030
type: ConferencePoster
type: Thing
type: BFO_0000002
included: Moléculas bioactivas 2019

In vitro characterization of a TRPV1 soft antagonist.
type: BFO_0000002
type: Conference
type: 2019
type: Thing
type: Anualidad
type: BFO_0000031
type: ConferencePaper
type: Document
type: Article
type: IAO_0000030
included: Moléculas bioactivas 2019
type: BFO_0000001

A new family of chiral heterocyclic compounds that blocks the TRPM8 activation.
type: 2019
type: Thing
type: IAO_0000030
type: Document
type: ConferencePoster
included: Moléculas bioactivas 2019
type: BFO_0000031
type: BFO_0000001
type: Anualidad
type: BFO_0000002
type: Conference

FASTBASE1.16ET
type: Anualidad
type: TransferenciaTecnologica
type: Year2016
type: ExplotacionLicencia
type: BFO_0000015
type: BFO_0000002
type: Year2020
type: BFO_0000003
type: BFO_0000020
type: Project
type: Proyecto
type: Grant
type: 2019
type: BFO_0000001
type: Year2018
type: Year2021
type: Relationship
type: Thing
type: Year2017
included: Moléculas bioactivas 2019

Study Chronic Effect of 17- ß -Estradiol Over Trp Channels In Nociceptor Terminals In Microfluidic Chambers.
type: Thing
type: ConferencePoster
type: BFO_0000031
included: Moléculas bioactivas 2019
type: BFO_0000002
type: Conference
type: 2019
type: BFO_0000001
type: Anualidad
type: IAO_0000030
type: Document

FERNÁNDEZ CARVAJAL, ASIA
type: PersonActive
type: Agent
type: BFO_0000001
type: Person
type: Thing
type: BFO_0000004
type: BFO_0000002
included: Moléculas bioactivas 2019

Mechanisms of blockade of the muscle-type nicotinic receptor by benzocaine, a permanently uncharged local anesthetic
type: BFO_0000031
type: BFO_0000002
type: BFO_0000001
included: Moléculas bioactivas 2019
type: AcademicArticle
type: Thing
type: IAO_0000030
type: Anualidad
type: Article
type: 2019
type: Document

FERRER MONTIEL, ANTONIO VICENTE
type: PersonActive
type: Agent
type: BFO_0000001
type: Person
type: Thing
type: BFO_0000004
type: BFO_0000002
included: Moléculas bioactivas 2019

The calmodulin-binding tetraleucine motif of KCNE4 is responsible for association with Kv1.3
type: Anualidad
type: BFO_0000031
type: IAO_0000030
type: BFO_0000002
type: AcademicArticle
type: 2019
included: Moléculas bioactivas 2019
type: Thing
type: Document
type: Article
type: BFO_0000001

Development of an in vitro pre-clinical nociceptor model for studying paclitaxel-induced neuropathic pain"
type: BFO_0000031
type: ConferencePoster
type: BFO_0000002
type: 2019
type: Conference
type: IAO_0000030
type: BFO_0000001
type: Anualidad
type: Document
type: Thing
included: Moléculas bioactivas 2019

Transdifferentiation and microfluidic chambers as tools to approach the in-vivo sketch of human nociceptors
type: BFO_0000002
type: 2019
type: BFO_0000001
type: Thing
type: Conference
included: Moléculas bioactivas 2019
type: Document
type: IAO_0000030
type: BFO_0000031
type: Anualidad
type: ConferencePoster

Identificación y caracterización de nuevos moduladores de TRPM8
type: Thing
type: Anualidad
type: BFO_0000001
type: Conference
type: ConferencePoster
type: IAO_0000030
type: Document
included: Moléculas bioactivas 2019
type: 2019
type: BFO_0000031
type: BFO_0000002

RTI2018-097189-B-C21
type: BFO_0000002
type: BFO_0000003
type: ProyectoInvestigacion
type: Year2021
type: Year2022
type: BFO_0000015
type: ERO_0000014
type: 2019
type: BFO_0000001
included: Moléculas bioactivas 2019
type: Thing
type: Anualidad
type: Grant
type: Year2020
type: OBI_0000011
type: Project
type: Relationship
type: BFO_0000020
type: Proyecto

GRISOLIA
type: Grant
type: Year2021
type: BFO_0000001
type: BFO_0000003
type: 2019
type: Relationship
type: Project
type: ProyectoInvestigacion
type: Proyecto
type: OBI_0000011
type: Thing
included: Moléculas bioactivas 2019
type: BFO_0000015
type: Year2022
type: ERO_0000014
type: Anualidad
type: BFO_0000002
type: BFO_0000020
type: Contratacion
type: Year2020

In vitro characterization of a TRPV1 soft antagonist.
type: BFO_0000031
type: Conference
type: ConferencePoster
type: Document
included: Moléculas bioactivas 2019
type: BFO_0000002
type: 2019
type: Anualidad
type: BFO_0000001
type: IAO_0000030
type: Thing

PROSPERABIOTECH1.16ET
type: Year2021
type: Year2018
type: Year2016
included: Moléculas bioactivas 2019
type: BFO_0000001
type: BFO_0000020
type: Project
type: 2019
type: Anualidad
type: Year2017
type: TransferenciaTecnologica
type: BFO_0000002
type: BFO_0000003
type: Grant
type: Relationship
type: Proyecto
type: Year2020
type: Thing
type: BFO_0000015
type: ExplotacionLicencia

Development of an in vitro pre-clinical nociceptor model for studying paclitaxel-induced neuropathic pain
type: Conference
type: BFO_0000002
type: Document
type: 2019
type: Thing
type: BFO_0000031
type: BFO_0000001
type: Anualidad
type: IAO_0000030
type: ConferencePoster
included: Moléculas bioactivas 2019

Contribution of hyperpolarizing ion channels to acute cold hypersensitivity induced by oxaliplatin administration.
type: BFO_0000002
type: IAO_0000030
type: Document
type: 2019
type: BFO_0000031
type: Conference
type: BFO_0000001
included: Moléculas bioactivas 2019
type: ConferencePoster
type: Thing
type: Anualidad

AVIZOREX1.16LP
type: Year2017
type: Year2020
type: BFO_0000003
type: BFO_0000002
type: TransferenciaTecnologica
type: Grant
included: Moléculas bioactivas 2019
type: Year2018
type: Relationship
type: Proyecto
type: ExplotacionLicencia
type: 2019
type: Year2021
type: BFO_0000020
type: Project
type: Thing
type: BFO_0000015
type: Anualidad
type: BFO_0000001

LIPOTEC1.99R
type: Grant
type: Year2015
type: BFO_0000002
type: Thing
type: Year2008
type: Year2013
type: Year2010
type: Year2006
type: Year2018
type: Year2016
type: BFO_0000003
included: Moléculas bioactivas 2019
type: Relationship
type: Anualidad
type: Year2004
type: Year2009
type: Year2011
type: Project
type: TransferenciaTecnologica
type: BFO_0000001
type: Year2014
type: BFO_0000015
type: ExplotacionLicencia
type: Year2020
type: Year2017
type: Proyecto
type: 2019
type: Year2005
type: Year2012
type: Year2007
type: BFO_0000020
type: Year2000

ANTALGENICS1.15ET
type: ExplotacionLicencia
type: Year2020
type: Year2021
type: BFO_0000020
type: Year2023
type: Year2018
type: Project
type: Year2016
type: BFO_0000001
type: Grant
type: Relationship
type: Year2015
type: TransferenciaTecnologica
type: Anualidad
type: BFO_0000003
type: Proyecto
type: 2019
type: Thing
type: Year2017
type: BFO_0000002
included: Moléculas bioactivas 2019
type: BFO_0000015
type: Year2022

Improving a Natural Compound: Design of innovative neurocosmeceuticals for sensitive skin
type: Thing
type: Article
type: ConferencePaper
type: IAO_0000030
type: 2019
included: Moléculas bioactivas 2019
type: Conference
type: BFO_0000002
type: BFO_0000001
type: BFO_0000031
type: Anualidad
type: Document

LIPOTEC1.14D
type: BFO_0000001
type: Anualidad
type: BFO_0000002
type: ExplotacionLicencia
type: Year2017
type: BFO_0000020
type: Grant
type: Year2018
type: Project
type: 2019
type: Thing
type: BFO_0000003
included: Moléculas bioactivas 2019
type: Relationship
type: TransferenciaTecnologica
type: BFO_0000015
type: Proyecto

ß -Lactam TRPM8 Antagonists Prevent Chemotherapy-Induced Cold Allodynia.
type: Anualidad
type: Conference
type: Document
type: Thing
included: Moléculas bioactivas 2019
type: BFO_0000031
type: BFO_0000001
type: BFO_0000002
type: 2019
type: IAO_0000030
type: Article
type: ConferencePaper